Utah Medical Products, Inc.

Utah Medical Products, Inc. (UTMD) is currently trading at $67.65, with a 52-week range of $52.0 to $71.81. Reaching the $81 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Whether Utah Medical Products, Inc. can reach $81 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Healthcare space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Historically, UTMD has delivered a -3.9% CAGR over the past 5 years, which suggests the stock has demonstrated meaningful long-term growth momentum. However, past performance does not guarantee future results, and short-term price movements can be influenced by macroeconomic shifts, interest rate changes, and investor sentiment. Use the UTMD Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Whether Utah Medical Products, Inc. (UTMD) is worth buying at $67.65 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Utah Medical Products, Inc. trades at a Price-to-Earnings (P/E) ratio of 19.2x, which can be compared against other Healthcare companies to assess whether the stock is expensive or attractively priced relative to its peers.

Profitability & efficiency: Utah Medical Products, Inc. has a Return on Capital Employed (ROCE) of 9.5%, which reflects modest capital efficiency. Its Return on Equity (ROE) stands at 9.1%.

Financial health: The Debt-to-Equity ratio of 0.17 indicates a conservative balance sheet with more equity than debt, reducing financial risk.

Analyst view: Analyst estimates are not currently available for UTMD. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

Analyst price target data for Utah Medical Products, Inc. (UTMD) is not currently available on StockSifting. Analyst coverage and price targets are typically published by brokerage research desks for widely followed stocks, and are updated regularly after earnings results or major corporate events. Check back for the latest estimates, or explore UTMD's financial ratios, historical returns, and fundamental data available on this page to form your own view.

Utah Medical Products, Inc. (UTMD) currently has a Price-to-Earnings (P/E) ratio of 19.2x, meaning investors are paying $19.2 for every $1 of the company's trailing twelve-month earnings. Whether this makes the stock overvalued depends on several contextual factors:

Sector context: The Healthcare sector tends to command higher valuation multiples when growth expectations are elevated. A 19.2x P/E falls within a moderate range, reflecting reasonable market confidence in Utah Medical Products, Inc.'s earnings outlook.

Growth-adjusted valuation: A P/E ratio in isolation can be misleading. Fast-growing companies often deserve higher P/E multiples because their future earnings are expected to rise significantly. A more complete picture comes from looking at the PEG ratio (P/E divided by earnings growth rate) — a PEG below 1 is often considered undervalued, while above 2 may signal overvaluation. Utah Medical Products, Inc.'s ROCE of 9.5% suggests it has moderate capital returns.

Additional metrics to review: P/E is just one lens. Compare it alongside the Price-to-Book (P/B) ratio, EV/EBITDA, Price-to-Sales, and free cash flow yield for a more complete valuation picture. View all of UTMD's valuation ratios on StockSifting's ratios section. Valuation is subjective and context-dependent — this is not investment advice.

Dividend reinvestment — commonly known as DRIP (Dividend Reinvestment Plan) — is a powerful wealth-building strategy where instead of receiving your dividend payouts as cash, the dividends are automatically used to purchase additional shares of Utah Medical Products, Inc. (UTMD). Over time, this creates a compounding effect: more shares generate more dividends, which buy even more shares.

Utah Medical Products, Inc. currently offers a dividend yield of approximately 194.00%. While this may seem modest in isolation, the real power of DRIP emerges over long holding periods. An investor who reinvested dividends consistently over 10–20 years would accumulate significantly more shares than one who took dividends as cash — and those extra shares continue generating their own dividend income.

The key variables that determine your DRIP returns are: your initial investment amount, the number of years you stay invested, the dividend yield at the time of each reinvestment, and whether Utah Medical Products, Inc. grows or cuts its dividend over time. Market price appreciation of UTMD also plays a significant role — rising share prices increase the value of your accumulated shares.

Use the UTMD DRIP Calculator on StockSifting to enter your investment amount, start date, and contribution frequency — and see a year-by-year breakdown of shares accumulated, dividends earned, and total portfolio value. Past dividend payments are not a guarantee of future payouts. This is not financial advice.